- Home
- A-Z Publications
- Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents)
- Previous Issues
- Volume 6, Issue 1, 2007
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents) - Volume 6, Issue 1, 2007
Volume 6, Issue 1, 2007
-
-
Editorial [Hot Topic: Kinase Targets and Inhibitors in Inflammation (Guest Editors: Khusru Asadullah and Matthias Gaestel)]
Authors: Khusru Asadullah and Matthias GaestelWhereas G protein-coupled and nuclear receptors have been in the focus of the pharmaceutical industry since decades, protein kinases became interesting drug targets more recently. Several protein kinase inhibitors are well established for the treatment of tumors in the meantime, many more are in clinical development. Inside into the biology of protein kinases and progress in technologies to target these molecules, howe Read More
-
-
-
Protein Kinase Inhibitors for the Treatment of Inflammation - An Overview
Authors: Khusru Asadullah and Matthias GaestelProtein kinases are key factors in signal transduction, playing a pivotal role in the initiation, propagation and regulation of immunologic responses. In contrast to protein- protein interaction they are considered to be “drugable” by small molecular weight inhibitors. Thus kinases moved into in the focus as promising drug targets for the therapy of inflammatory and autoimmune diseases. Whereas some kinase inhibitors are in clinic Read More
-
-
-
Structural Aspects of Drugability and Selectivity of Protein Kinases in Inflammation
Authors: Martina Schafer and Ursula EgnerProtein kinases are major drug targets in pharmaceutical companies. A deep understanding of the features of the ATP binding niche is of utmost importance for the assessment of drugability and selectivity. This article focuses on recent developments in experimental and theoretical methods relating to structural aspects of drugability and selectivity. Predicting drugability is enabled by a detailed analysis of the structural charac Read More
-
-
-
Kinases as Drug Targets in Inflammation: In Vitro and In Vivo Target Validation and Expression Profiling
Authors: Tatjana Clarissa Gust and Arne v. BoninInflammation seems to be at the beginning of the majority of chronic diseases, and major efforts are dedicated to the development of anti-inflammatory drugs. Chronic inflammatory diseases, such as psoriatic arthritis, rheumatoid arthritis, inflammatory bowel disease and asthma, are diseases that affect a large segment of our population. Recent evidence suggests that even metabolic diseases, such as type 2 diabetes, Read More
-
-
-
In Vivo Target Validation: Methodology and Case Studies on the Janus Kinase Tyk2
Authors: Christian Gausterer, Mathias Muller and Birgit StroblDysregulated protein kinase activity can cause severe human diseases. Consequently, there is a growing number of kinases that constitute candidate targets for pharmaceutical intervention. However, target validation is critical, since not all kinases are “druggable”, i.e. suitable as a selective drug target. In this review, we briefly introduce major strategies for generating mouse models to analyse and control the expr Read More
-
-
-
Tyrosine Kinases as Targets for Anti-Inflammatory Therapy
Authors: Teruko Tamura and Alexandra KochTyrosine kinases play key roles in cell proliferation, differentiation, survival, cell migration, tissue development, and cell metabolisms. Mutation and /or truncation in tyrosine kinases result in their constitutive activation independent of ligand stimulation. The constitutively activated tyrosine kinase often triggers cancer development. Furthermore, it is well documented that overexpression of tyrosine kinases is involved in malignancy Read More
-
-
-
The Role of Tec Family Kinases in Inflammatory Processes
Authors: Martin Melcher, Julia Raberger, Uwe Schmidt, Bernd Unger and Wilfried EllmeierA variety of different cell lineages of the hematopoietic system are activated during inflammatory processes. These cells not only contribute to the beneficial outcome of an immune response, but can also cause pathology such as autoimmunity as a consequence of extended or uncontrolled reactions. Therefore, an understanding of the basic mechanisms that lead to immune cell activation and the identification of key molecu Read More
-
-
-
Targeting Strategies to Modulate the NF-κB and JNK Signal Transduction Network
More LessThe signal transduction pathways leading to activation of Jun-NH2-terminal kinase (JNK) and nuclear factor- κB (NF-κB) are activated by a plethora of extracellular signals. Small molecules have been developed that inhibit the JNK or IκB protein kinases. Additionally, several cell-penetrating peptides have been characterized that disrupt proteinprotein interaction domains within the NF-κB and JNK signalling pathways. Usually Read More
-
-
-
The ERK and p38MAPK Pathways as Targets for Anti-Inflammatory Therapy
Authors: Edward Hitti and Alexey KotlyarovSequential activation of kinases (protein kinase cascades) is a general mechanism of signal transduction in many cellular processes. Several related intracellular signaling cascades have been found and characterized in the last 25 years known as mitogen-activated protein kinase (MAPK) signaling cascades. These cascades cooperate in transmitting extracellular signals to their intracellular targets and thus initiate cellular processes Read More
-
Volumes & issues
-
Volume 24 (2025)
-
Volume 23 (2024)
-
Volume 22 (2023)
-
Volume 21 (2022)
-
Volume 20 (2021)
-
Volume 19 (2020)
-
Volume 18 (2019)
-
Volume 17 (2018)
-
Volume 16 (2017)
-
Volume 15 (2016)
-
Volume 14 (2015)
-
Volume 13 (2014)
-
Volume 12 (2013)
-
Volume 11 (2012)
-
Volume 10 (2011)
-
Volume 9 (2010)
-
Volume 8 (2009)
-
Volume 7 (2008)
-
Volume 6 (2007)
-
Volume 5 (2006)
Most Read This Month
Article
content/journals/aiaamc
Journal
10
5
false
en
